Medical Research
Hope For Pdcd Foundation
FOLSOM, CA
Total revenue
$330K
Total expenses
$178K
Net assets
$558K
Grants received
$236K
11 grants
EIN
920361943
Tax year
2024
Mission
Support and fund the development of life-saving treatment for patients with pyruvate dehydrogenase complex deficiency and related genetic diseases.
Programs
1 program
Childrens Hospital of Philadelphia Activity Assay focuses on optimizing the detection of acetyl-CoA which is crucial for PDCD within the mass spectrometry instruments sensitivity range. The study compares media versus cells with reduced interference. Various PDCD lines mild vs. severe will be examined and contrasted. Additionally PDCD will be compared with other tricarboxylic cycle deficiencies and ETC defects to ensure distinguishability.
Financials
FY 2024
Revenue
Expenses
People
13 listed
Frances Pimentel
Chief Executive Officer
—
10 hrs/wk
Jon Pimentel
Chief Financial Officer
—
5 hrs/wk
Kimberlee Muenzer
Secretary
—
1 hrs/wk
Kim Higbee
Director
—
1 hrs/wk
Katy Cairo
Director
—
1 hrs/wk
Patricia Medlen
Director
—
1 hrs/wk
Carly Tasiopoulos
Director
—
1 hrs/wk
Chris Tasiopoulos
Director
—
1 hrs/wk
Nikki Kulovitz
Director
—
1 hrs/wk
Molly Naccarato
Director
—
1 hrs/wk
Brandy Jackson
Director
—
1 hrs/wk
Layna O'Connor
Director
—
1 hrs/wk
Natasha Baril
Director
—
1 hrs/wk
Grants received
Showing 11 of 11
Funded by
$236K from 8 funders · 11 grants · 2022–2024
$104K · 3 grants · 2022–2024
$53K · 1 grant · 2024
$36K · 1 grant · 2023
$27K · 1 grant · 2023
$10K · 1 grant · 2024
$7K · 2 grants · 2023–2024
$200 · 1 grant · 2024
$100 · 1 grant · 2022